A review of the preclinical and clinical data of newer intranasal steroids used in the treatment of allergic rhinitis
- 1 October 1999
- journal article
- review article
- Published by Elsevier in Journal of Allergy and Clinical Immunology
- Vol. 104 (4) , s150-s159
- https://doi.org/10.1016/s0091-6749(99)70311-8
Abstract
No abstract availableKeywords
This publication has 28 references indexed in Scilit:
- Effects of repeated once daily dosing of three intranasal corticosteroids on basal and dynamic measures of hypothalamic-pituitary-adrenal–axis activityJournal of Allergy and Clinical Immunology, 1998
- Intranasal Fluticasone PropionateDrugs, 1997
- Triamcinolone AcetonideDrugs, 1997
- Clinical review of once-daily beclomethasone dipropionate for seasonal allergic rhinitisClinical Therapeutics, 1996
- A placebo- and active-controlled randomized trial of prophylactic treatment of seasonal allergic rhinitis with mometasone furoate aqueous nasal sprayJournal of Allergy and Clinical Immunology, 1996
- Once Daily Mometasone Furoate Aqueous Nasal Spray Is As Effective as Twice Daily Beclomethasone Dipropionate for Treating Perennial Allergic Rhinitis PatientsAnnals of Allergy, Asthma & Immunology, 1996
- 62 Lack of systemic activity with intranasal mometasone furoateJournal of Allergy and Clinical Immunology, 1996
- Pharmacokinetics of Triamcinolone Acetonide After Intravenous, Oral, and Inhaled AdministrationThe Journal of Clinical Pharmacology, 1995
- BudesonideDrugs, 1992
- Inhibition of Mediator Release in Allergic Rhinitis by Pretreatment with Topical GlucocorticosteroidsNew England Journal of Medicine, 1987